BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 31628193)

  • 21. Deregulation of FGFR1 and CDK6 oncogenic pathways in acute lymphoblastic leukaemia harbouring epigenetic modifications of the MIR9 family.
    Rodriguez-Otero P; Román-Gómez J; Vilas-Zornoza A; José-Eneriz ES; Martín-Palanco V; Rifón J; Torres A; Calasanz MJ; Agirre X; Prosper F
    Br J Haematol; 2011 Oct; 155(1):73-83. PubMed ID: 21810092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-139-5p suppresses osteosarcoma cell growth and invasion through regulating DNMT1.
    Shi YK; Guo YH
    Biochem Biophys Res Commun; 2018 Sep; 503(2):459-466. PubMed ID: 29673587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 3,6-Dihydroxyflavone regulates microRNA-34a through DNA methylation.
    Peng X; Chang H; Chen J; Zhang Q; Yu X; Mi M
    BMC Cancer; 2017 Sep; 17(1):619. PubMed ID: 28870206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased miR-30b-5p expression by DNMT1 methylation regulation involved in gastric cancer metastasis.
    Qiao F; Zhang K; Gong P; Wang L; Hu J; Lu S; Fan H
    Mol Biol Rep; 2014 Sep; 41(9):5693-700. PubMed ID: 24913034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNMT1 mediated promoter methylation of GNAO1 in hepatoma carcinoma cells.
    Xu D; Du M; Zhang J; Xiong P; Li W; Zhang H; Xiong W; Liu F; Liu J
    Gene; 2018 Jul; 665():67-73. PubMed ID: 29709639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptional activation of the miR-17-92 cluster is involved in the growth-promoting effects of MYB in human Ph-positive leukemia cells.
    Spagnuolo M; Regazzo G; De Dominici M; Sacconi A; Pelosi A; Korita E; Marchesi F; Pisani F; Magenta A; Lulli V; Cordone I; Mengarelli A; Strano S; Blandino G; Rizzo MG; Calabretta B
    Haematologica; 2019 Jan; 104(1):82-92. PubMed ID: 30076175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-377 reverses cancerous phenotypes of pancreatic cells via suppressing DNMT1 and demethylating tumor suppressor genes.
    Azizi M; Fard-Esfahani P; Mahmoodzadeh H; Fazeli MS; Azadmanesh K; Zeinali S; Teimoori-Toolabi L
    Epigenomics; 2017 Aug; 9(8):1059-1075. PubMed ID: 28758420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression.
    Chen DL; Wang ZQ; Zeng ZL; Wu WJ; Zhang DS; Luo HY; Wang F; Qiu MZ; Wang DS; Ren C; Wang FH; Chiao LJ; Pelicano H; Huang P; Li YH; Xu RH
    Hepatology; 2014 Aug; 60(2):598-609. PubMed ID: 24616020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Constitutive Notch pathway activation in murine ZMYM2-FGFR1-induced T-cell lymphomas associated with atypical myeloproliferative disease.
    Ren M; Cowell JK
    Blood; 2011 Jun; 117(25):6837-47. PubMed ID: 21527531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-377 induces senescence in human skin fibroblasts by targeting DNA methyltransferase 1.
    Xie HF; Liu YZ; Du R; Wang B; Chen MT; Zhang YY; Deng ZL; Li J
    Cell Death Dis; 2017 Mar; 8(3):e2663. PubMed ID: 28277545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNMT1 mediates chemosensitivity by reducing methylation of miRNA-20a promoter in glioma cells.
    Zhou D; Wan Y; Xie D; Wang Y; Wei J; Yan Q; Lu P; Mo L; Xie J; Yang S; Qi X
    Exp Mol Med; 2015 Sep; 47(9):e182. PubMed ID: 26337869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of human glioma cell apoptosis and invasion by miR-152-3p through targeting DNMT1 and regulating NF2 : MiR-152-3p regulate glioma cell apoptosis and invasion.
    Sun J; Tian X; Zhang J; Huang Y; Lin X; Chen L; Zhang S
    J Exp Clin Cancer Res; 2017 Aug; 36(1):100. PubMed ID: 28764788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutation in the FGFR1 tyrosine kinase domain or inactivation of PTEN is associated with acquired resistance to FGFR inhibitors in FGFR1-driven leukemia/lymphomas.
    Cowell JK; Qin H; Hu T; Wu Q; Bhole A; Ren M
    Int J Cancer; 2017 Nov; 141(9):1822-1829. PubMed ID: 28646488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of DNA methylation and tumor suppression gene expression by miR-29b in leukemia patients and related mechanisms.
    Chen YL; Zhang ZX; Shou LH; Di JY
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):158-165. PubMed ID: 29364483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antagonistic activities of miR-148a and DNMT1: Ectopic expression of miR-148a impairs DNMT1 mRNA and dwindle cell proliferation and survival.
    Sengupta D; Deb M; Patra SK
    Gene; 2018 Jun; 660():68-79. PubMed ID: 29596883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Src activation plays an important key role in lymphomagenesis induced by FGFR1 fusion kinases.
    Ren M; Qin H; Ren R; Tidwell J; Cowell JK
    Cancer Res; 2011 Dec; 71(23):7312-22. PubMed ID: 21937681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kindlin-2 interacts with and stabilizes DNMT1 to promote breast cancer development.
    Wang P; Chu W; Zhang X; Li B; Wu J; Qi L; Yu Y; Zhang H
    Int J Biochem Cell Biol; 2018 Dec; 105():41-51. PubMed ID: 30287284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylation-associated miR-193b silencing activates master drivers of aggressive prostate cancer.
    Mazzu YZ; Yoshikawa Y; Nandakumar S; Chakraborty G; Armenia J; Jehane LE; Lee GM; Kantoff PW
    Mol Oncol; 2019 Sep; 13(9):1944-1958. PubMed ID: 31225930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silencing of miR-152 contributes to DNMT1-mediated CpG methylation of the PTEN promoter in bladder cancer.
    Liu P; Wu L; Chand H; Li C; Hu X; Li Y
    Life Sci; 2020 Nov; 261():118311. PubMed ID: 32861793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.